Variable | Ward inpatients (n = 23) | ICU inpatients (n = 23) |
---|---|---|
Age (yrs), median (IQR) | 60.0 (20.0) | 60.0 (17.0) |
Male sex, no. (%) | 13 (56.5) | 13 (56.5) |
Weight (kg), median (IQR) | 86.0 (13.4) | 89.8 (26.5) |
Height (cm), median (IQR) | 170.0 (8.0) | 171.0 (8.5) |
BMI, median (IQR) | 28.1 (5.4) | 30.3 (7.1) |
MODS, median (IQR) | – | 5.0 (1.8) |
SOFA score, median (IQR) | – | 6.0 (5.5) |
Comorbidities, no. (%) | Â | Â |
 Diabetes | 4 (17.4) | 10 (43.5) |
 Hypertension | 9 (39.1) | 10 (43.5) |
 Coronary artery/heart disease | 1 (4.3) | 2 (8.7) |
 Chronic/congestive heart failure | 0 (0.0) | 0 (0.0) |
 Chronic kidney disease | 1 (4.3) | 2 (8.7) |
 Cancer | 3 (13.0) | 2 (8.7) |
 COPD | 0 (0.0) | 1 (4.3) |
Presenting symptoms, no. (%) | Â | Â |
 Fever | 18 (78.3) | – |
 Cough | 19 (82.6) | – |
 Anosmia/ageusia | 5 (21.7) | – |
 Pharyngitis | 5 (21.7) | – |
 Headache | 3 (13.0) | – |
 Myalgias | 14 (60.9) | – |
 Dyspnea | 20 (87.0) | – |
 Chest pain | 3 (13.0) | – |
 Nausea/vomiting/diarrhea | 10 (43.5) | – |
Pulmonary pathology, no. (%) | Â | Â |
 Unilateral pneumonia | – | 1 (4.3) |
 Bilateral pneumonia | 22 (95.7) | 21 (91.3) |
 Interstitial infiltrates/R effusion | – | 1 (4.3) |
Laboratories, median (IQR) | Â | Â |
 Hemoglobin | 130.0 (24.0) | 119.0 (28.5) |
 White blood cell count | 7.0 (5.0) | 8.8 (7.5) |
 Neutrophils | 5.9 (4.2) | 7.6 (6.9) |
 Lymphocytes | 0.8 (0.6) | 0.7 (0.6) |
 Platelets | 219.0 (80.5) | 216.0 (131.0) |
 Creatinine | 70.0 (28.5) | 81.0 (113.5) |
 International normalized ratio | 1.1 (0.1) | 1.2 (0.1) |
 Lactate | 1.7 (1.0) | 1.3 (0.8) |
 Partial thromboplastin time (PTT) | – | 27.0 (5.0) |
 PaO2/FiO2 Ratio | – | 128.0 (70.0) |
Interventions, no. (%) | Â | Â |
 Renal replacement therapy | 0 (0.0) | 6 (26.1) |
 High-flow nasal cannula | 13 (56.5) | 15 (65.2) |
 Non-invasive mechanical ventilation | 1 (4.3) | 7 (30.4) |
 Invasive mechanical ventilation | 2 (8.7) | 21 (91.3) |
 Extracorporeal membrane oxygenation | 0 (0.0) | 1 (4.3) |
 Tocilizumab | 2 (8.7) | 0 (0.0) |
 Steroids | 22 (95.7) | 15 (65.2) |
 Vasoactive medications | 2 (9.5) | 19 (82.6) |
 Antibiotics | 22 (95.7) | 23 (100.0) |
 Anti-virals | 5 (21.7) | 3 (13.0) |
 Antiplatelet | 4 (17.4) | 18 (78.3) |
 Anticoagulation | 23 (100.0) | 22 (95.6) |
Outcomes | Â | Â |
 Days, median (IQR) | 8.0 (7.0) | 15.0 (14.0) |
 Died, no. (%) | 2 (8.7) | 11 (47.8) |